ReVision Implant announced today that it received FDA breakthrough device designation for its Occular visual cortical prosthesis.
Executive VP of Vision Science, Dr. Len Zheleznyak, to present performance data on the world's only diffractive multifocal soft contact lens and new findings on the "Optical Signatures" of myopia ...
Medical Device Network on MSN
ReVision Implant eyes FIH trial for BCI after FDA breakthrough designation
ReVision now anticipates initiating early-stage human clinical trials of its Occular BCI in blind volunteers in 2027.
Reading vision can worsen with age, but a breakthrough two-step lens procedure could potentially cure the often inevitable vision problem. The lens is part of an FDA study taking place in Southern ...
This breakthrough innovation sets new standards for modern eyewear by combining electro-optics, AI and the expertise of eyecare professionals (ECPs) worldwide. Percept Corporation is introducing ...
LAS VEGAS, NV, UNITED STATES, January 7, 2026 /EINPresswire.com/ — As the International Consumer Electronics Show (CES) 2026 opens its doors in Las Vegas, the ...
Percept Corporation announces the formation of the AI Optical Consortium (AOC) for major tech/AI and vision companies to join Percept Corporation in solving the problem of the world’s lack of access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results